Clinical Trial Update: The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health [NA]

View source ↗

Summary

A completed clinical trial evaluated the impact of the KETO5 XOGenius Beverage on physiological and neurocognitive health markers in adults with cardiovascular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Cognitive Decline
• Hypertension

Drugs mentioned

• KETO5 XOGenius Beverage

Snippet

Sponsor: The University of Texas at Arlington | Conditions: Cardiovascular Diseases, Hypertension | NA | Status: COMPLETED